Surgery Partners (SGRY) Lifted to “Sell” at BidaskClub
BidaskClub upgraded shares of Surgery Partners (NASDAQ:SGRY) from a strong sell rating to a sell rating in a report issued on Tuesday morning.
SGRY has been the subject of a number of other reports. Jefferies Group decreased their target price on Surgery Partners from $16.00 to $13.00 and set a buy rating for the company in a research note on Wednesday, November 1st. Bank of America decreased their target price on Surgery Partners from $23.00 to $19.00 and set a buy rating for the company in a research note on Monday, October 9th. KeyCorp restated a hold rating on shares of Surgery Partners in a research note on Tuesday, October 31st. Royal Bank of Canada restated a buy rating and issued a $18.00 target price on shares of Surgery Partners in a research note on Sunday, November 12th. Finally, Zacks Investment Research upgraded Surgery Partners from a strong sell rating to a hold rating in a research note on Wednesday, October 11th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. Surgery Partners has an average rating of Hold and an average target price of $18.57.
Surgery Partners (NASDAQ SGRY) traded up $1.40 during trading hours on Tuesday, reaching $11.15. The company had a trading volume of 1,461,710 shares, compared to its average volume of 416,494. The firm has a market capitalization of $475.50, a P/E ratio of 65.00 and a beta of 1.89. Surgery Partners has a fifty-two week low of $7.10 and a fifty-two week high of $24.05. The company has a quick ratio of 1.92, a current ratio of 2.09 and a debt-to-equity ratio of 1.56.
A number of hedge funds have recently modified their holdings of SGRY. Voya Investment Management LLC bought a new stake in shares of Surgery Partners during the second quarter valued at approximately $222,000. Royal Bank of Canada raised its holdings in shares of Surgery Partners by 680.5% during the second quarter. Royal Bank of Canada now owns 10,544 shares of the company’s stock valued at $240,000 after buying an additional 9,193 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in shares of Surgery Partners by 211.4% during the second quarter. Russell Investments Group Ltd. now owns 11,915 shares of the company’s stock valued at $271,000 after buying an additional 8,089 shares during the last quarter. Citadel Advisors LLC bought a new stake in shares of Surgery Partners during the third quarter valued at approximately $129,000. Finally, Campbell Newman Asset Management Inc. raised its holdings in shares of Surgery Partners by 4.9% during the second quarter. Campbell Newman Asset Management Inc. now owns 12,649 shares of the company’s stock valued at $288,000 after buying an additional 586 shares during the last quarter. Institutional investors own 94.16% of the company’s stock.
WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/12/16/surgery-partners-sgry-lifted-to-sell-at-bidaskclub.html.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Stock Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related stocks with our FREE daily email newsletter.